Literature DB >> 33067333

Inflammatory bowel disease and Parkinson's disease: common pathophysiological links.

Ho-Su Lee1,2, Evy Lobbestael3, Séverine Vermeire4,5, João Sabino4,5, Isabelle Cleynen6.   

Abstract

Inflammatory bowel disease and Parkinson's disease are chronic progressive disorders that mainly affect different organs: the gut and brain, respectively. Accumulating evidence has suggested a bidirectional link between gastrointestinal inflammation and neurodegeneration, in accordance with the concept of the 'gut-brain axis'. Moreover, recent population-based studies have shown that inflammatory bowel disease might increase the risk of Parkinson's disease. Although the precise mechanisms underlying gut-brain interactions remain elusive, some of the latest findings have begun to explain the link. Several genetic loci are shared between both disorders with a similar direction of effect on the risk of both diseases. The most interesting example is LRRK2 (leucine-rich repeat kinase 2), initially identified as a causal gene in Parkinson's disease, and recently also implicated in Crohn's disease. In this review, we highlight recent findings on the link between these seemingly unrelated diseases with shared genetic susceptibility. We discuss supporting and conflicting data obtained from epidemiological and genetic studies along with remaining questions and concerns. In addition, we discuss possible biological links including the gut-brain axis, microbiota, autoimmunity, mitochondrial function and autophagy. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  IBD - genetics; IBD basic research; Parkinson's disease; epidemiology; inflammatory bowel disease

Mesh:

Year:  2020        PMID: 33067333     DOI: 10.1136/gutjnl-2020-322429

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  30 in total

Review 1.  Mitochondria and Inflammatory Bowel Diseases: Toward a Stratified Therapeutic Intervention.

Authors:  Gwo-Tzer Ho; Arianne L Theiss
Journal:  Annu Rev Physiol       Date:  2021-10-06       Impact factor: 19.318

Review 2.  The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic.

Authors:  Ai Huey Tan; Shen Yang Lim; Anthony E Lang
Journal:  Nat Rev Neurol       Date:  2022-06-24       Impact factor: 44.711

Review 3.  Epidemiological Evidence for an Immune Component of Parkinson's Disease.

Authors:  Paulina Gonzalez-Latapi; Connie Marras
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 4.  The Pathological Mechanism Between the Intestine and Brain in the Early Stage of Parkinson's Disease.

Authors:  Runing Yang; Ge Gao; Hui Yang
Journal:  Front Aging Neurosci       Date:  2022-06-24       Impact factor: 5.702

5.  Exploration of the Common Gene Characteristics and Molecular Mechanism of Parkinson's Disease and Crohn's Disease from Transcriptome Data.

Authors:  Haoran Zheng; Xiaohang Qian; Wotu Tian; Li Cao
Journal:  Brain Sci       Date:  2022-06-13

6.  Serum and Fecal Markers of Intestinal Inflammation and Intestinal Barrier Permeability Are Elevated in Parkinson's Disease.

Authors:  Laura Dumitrescu; Daciana Marta; Adela Dănău; Antonia Lefter; Delia Tulbă; Liviu Cozma; Emilia Manole; Mihaela Gherghiceanu; Laura Cristina Ceafalan; Bogdan Ovidiu Popescu
Journal:  Front Neurosci       Date:  2021-06-18       Impact factor: 4.677

7.  Gastrointestinal Dopamine in Inflammatory Bowel Diseases: A Systematic Review.

Authors:  Magdalena Kurnik-Łucka; Paweł Pasieka; Patrycja Łączak; Marcin Wojnarski; Michał Jurczyk; Krzysztof Gil
Journal:  Int J Mol Sci       Date:  2021-11-29       Impact factor: 5.923

Review 8.  TLR2 and TLR4 in Parkinson's disease pathogenesis: the environment takes a toll on the gut.

Authors:  Anastazja M Gorecki; Chidozie C Anyaegbu; Ryan S Anderton
Journal:  Transl Neurodegener       Date:  2021-11-17       Impact factor: 8.014

Review 9.  Intestinal Inflammation and Parkinson's Disease.

Authors:  Yu Li; Yuanyuan Chen; Lili Jiang; Jingyu Zhang; Xuhui Tong; Dapeng Chen; Weidong Le
Journal:  Aging Dis       Date:  2021-12-01       Impact factor: 6.745

10.  The human microbiome and COVID-19: A systematic review.

Authors:  Shinya Yamamoto; Makoto Saito; Azumi Tamura; Diki Prawisuda; Taketoshi Mizutani; Hiroshi Yotsuyanagi
Journal:  PLoS One       Date:  2021-06-23       Impact factor: 3.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.